Nipro : New Year's Message from Sano Yoshihiko, President of NIPRO CORPORATION (January 5, 2023)
January 04, 2023
Share
January 5, 2023
NIPRO CORPORATION
New Year's Message from Sano Yoshihiko,
President of NIPRO CORPORATION (January 5, 2023)
During the morning address on Thursday, January 5, 2023, NIPRO CORPORATION President Sano Yoshihiko delivered his 2023 New Year's message.
[Theme] Striving for sustainable growth and development through high-profit corporate operation
[Summary]
As countries increasingly prioritize economic activity over countermeasures against the novel coronavirus, the world economy is showing increased signs of recovery.
Looking back over the last year, however, we see a variety of issues in addition to the pandemic, including Russia's prolonged invasion of Ukraine-which has led to increased shortages-and rising global interest rates, resulting in skyrocketing logistics and raw material costs. Japan's weak yen has also caused a sharp increase in the price of imports, leading to higher costs for various items. Nevertheless, global demand for medical products has continued to grow, and NIPRO is dedicated to overcoming today's various challenges by increasing production through its sales and logistics efforts.
Under the company's philosophy of "ONE NIPRO" and its corporate creed of "Willingness," the NIPRO Group will continue doing everything necessary to ensure profitability while also promoting sustainable growth and development throughout the Group.
10 goals for achieving 1 trillion yen in consolidated net sales by 2030
Increase production, sales, technical, and organizational management capabilities
Achieve fully automated production and inspection of all products
Develop automated sales planning software and automated production and inventory management software
Develop products with lasting demand from users
Comply with all relevant laws, regulations, and public rules
Improve the accuracy of performance-based allocation based on corporate performance
Reduce costs by optimizing cost transfers
Further the standardization and efficiency of operations and improve safety performance in the medical treatment front line through the systematization of medical care
Further strengthen in-house sustainability initiatives
Expand NIPRO's product areas (e.g., treatment, testing, hygiene)
Attachments
Original Link
Original Document
Permalink
Disclaimer
Nipro Corporation published this content on 05 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 January 2023 05:49:08 UTC.
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.